41 – 50 of 51
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Long-term safety and efficacy of drug-eluting and bare metal stents in saphenous vein grafts
(
- Contribution to journal › Article
-
Mark
Comparison of two drug-eluting balloons: a report from the SCAAR registry.
(
- Contribution to journal › Article
-
Mark
Clinical Impact of Second-Generation Everolimus-Eluting Stent Compared With First-Generation Drug-Eluting Stents in Diabetes Mellitus Patients Insights From a Nationwide Coronary Intervention Register
(
- Contribution to journal › Article
-
Mark
Lower risk of stent thrombosis and restenosis with unrestricted use of onew-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
- 2011
-
Mark
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
(
- Contribution to journal › Article
-
Mark
Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-A case-control study
(
- Contribution to journal › Article
- 2010
-
Mark
Thrombus aspiration in ST-elevation myocardial infarction in Sweden A short report on real world outcome
(
- Contribution to journal › Letter
-
Mark
Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale
(
- Contribution to journal › Article
-
Mark
Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
- 2009
-
Mark
Röntgenkontrastmedel och njurskador. Bättre uppfattning om riskmarkörer och uppföljning behövs.
(
- Contribution to journal › Article